These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 17959622)

  • 1. DES or BMS in acute myocardial infarction?
    Vlaar PJ; de Smet BJ; Zijlstra F
    Eur Heart J; 2007 Nov; 28(22):2693-4. PubMed ID: 17959622
    [No Abstract]   [Full Text] [Related]  

  • 2. A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale.
    Ribichini F; Tomai F; De Luca G; Boccuzzi G; Presbitero P; Pesarini G; Ferrero V; Ghini AS; Pastori F; De Luca L; Zavalloni D; Soregaroli D; Garbo R; Franchi E; Marino P; Minelli M; Vassanelli C
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):192-9. PubMed ID: 19377384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of the real-world use of drug-eluting stents at 9-month follow-up: results from the Sicilian DES Registry.
    Tamburino C; Barbagallo R; Capodanno D; di Matteo S; Colombo GL; Recchia M; Ciriminna S;
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):322-9. PubMed ID: 19430343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of drug-eluting stents in ST-segment elevation myocardial infarction: a meta-analysis of randomized trials.
    De Luca G; Stone GW; Suryapranata H; Laarman GJ; Menichelli M; Kaiser C; Valgimigli M; Di Lorenzo E; Dirksen MT; Spaulding C; Pittl U; Violini R; Percoco G; Marino P
    Int J Cardiol; 2009 Apr; 133(2):213-22. PubMed ID: 18394731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-eluting stents are associated with similar cardiovascular outcomes when compared to bare metal stents in the setting of acute myocardial infarction.
    Slottow TL; Steinberg DH; Roy P; Javaid A; Buch AN; Okabe T; Xue Z; Smith K; Torguson R; Pichard AD; Satler LF; Suddath WO; Kent KM; Waksman R
    Cardiovasc Revasc Med; 2008; 9(1):24-8. PubMed ID: 18206634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies.
    Kirtane AJ; Gupta A; Iyengar S; Moses JW; Leon MB; Applegate R; Brodie B; Hannan E; Harjai K; Jensen LO; Park SJ; Perry R; Racz M; Saia F; Tu JV; Waksman R; Lansky AJ; Mehran R; Stone GW
    Circulation; 2009 Jun; 119(25):3198-206. PubMed ID: 19528338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel-eluting versus bare-metal stents in acute ST elevation myocardial infarction (STEMI).
    Hamirani YS; Jibrin I; Abraham D; Merriman B; Wenz C; Bahr RD
    Crit Pathw Cardiol; 2008 Dec; 7(4):232-8. PubMed ID: 19050419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical impact of sirolimus-eluting stent in ST-segment elevation myocardial infarction: a meta-analysis of randomized clinical trials.
    Piscione F; Piccolo R; Cassese S; Galasso G; Chiariello M
    Catheter Cardiovasc Interv; 2009 Aug; 74(2):323-32. PubMed ID: 19360858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Off-label use of stents: bare-metal versus drug-eluting stents.
    Girod JP; Mulukutla SR; Marroquin OC
    Expert Rev Cardiovasc Ther; 2008 Sep; 6(8):1095-106. PubMed ID: 18793112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes of serolimus-eluting stents versus bare metal stents in ST-segment elevation myocardial infarction patients: a meta-analysis.
    Pan XH; Zhong WZ; Xiang MX; Xu G; Shan J; Wang JA
    Chin Med J (Engl); 2009 Jan; 122(1):88-92. PubMed ID: 19187623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of drug-eluting versus bare-metal stenting used according to on- and off-label criteria.
    Carlsson J; James SK; Lindbäck J; Scherstén F; Nilsson T; Stenestrand U; Lagerqvist B;
    J Am Coll Cardiol; 2009 Apr; 53(16):1389-98. PubMed ID: 19371822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel-eluting coronary stents in patients with diabetes mellitus: pooled analysis from 5 randomized trials.
    Kirtane AJ; Ellis SG; Dawkins KD; Colombo A; Grube E; Popma JJ; Fahy M; Leon MB; Moses JW; Mehran R; Stone GW
    J Am Coll Cardiol; 2008 Feb; 51(7):708-15. PubMed ID: 18279734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-eluting compared with bare-metal coronary stents among elderly patients.
    Groeneveld PW; Matta MA; Greenhut AP; Yang F
    J Am Coll Cardiol; 2008 May; 51(21):2017-24. PubMed ID: 18498954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of six-month outcomes for primary percutaneous revascularization for acute myocardial infarction with drug-eluting versus bare metal stents (from the APEX-AMI study).
    Patel MR; Pfisterer ME; Betriu A; Widmisky P; Holmes DR; O'Neill WW; Stebbins A; Van de Werf F; Armstrong PW; Granger CB;
    Am J Cardiol; 2009 Jan; 103(2):181-6. PubMed ID: 19121433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality following placement of drug-eluting and bare-metal stents for ST-segment elevation acute myocardial infarction in the Global Registry of Acute Coronary Events.
    Steg PG; Fox KA; Eagle KA; Furman M; Van de Werf F; Montalescot G; Goodman SG; Avezum A; Huang W; Gore JM;
    Eur Heart J; 2009 Feb; 30(3):321-9. PubMed ID: 19147604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The costs of drug-eluting coronary stents among Medicare beneficiaries.
    Groeneveld PW; Matta MA; Greenhut AP; Yang F
    Am Heart J; 2008 Jun; 155(6):1097-105. PubMed ID: 18513525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome of patients of over 85 years old with acute coronary syndrome undergoing percutaneous coronary stenting: a comparison of bare metal stent and drug eluting stent.
    Ma HY; Zhou YJ; Dick RJ; Shi DM; Liu YY; Cheng WJ; Guo YH; Wang JL; Ge HL
    Chin Med J (Engl); 2008 May; 121(10):887-91. PubMed ID: 18706201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy update on first-generation drug-eluting stents.
    Spaulding C
    Am J Cardiol; 2008 Nov; 102(9 Suppl):18J-23J. PubMed ID: 18928788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and effectiveness of drug-eluting stents among diabetic patients: a propensity analysis.
    Ko DT; Chiu M; Austin PC; Bowen J; Cohen EA; Tu JV
    Am Heart J; 2008 Jul; 156(1):125-34. PubMed ID: 18585507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.